|
ANIMAL
HEALTH TREATMENTS AND MAINTENANCE
MANAGEMENT
The sheep industry is doing an excellent job of minimizing violative
drug residues in lamb and mutton. Control of violative residues has
been accomplished by placing emphasis on the identification and handling
of individually treated sheep. This includes identifying each animal
treated; accurately recording the treatment, treatment date and treatment
dosage; and following prescribed withdrawal times.
Flock owners are encouraged to work regularly with their veterinarian
to develop flock health programs tailored to the specific needs of their
sheep. The program developed should be practical and cost-effective.
The benefits will include increased flock productivity, well-being and
profitability. Such a program will ensure that breeding stock are healthy
and sheep products are safe and wholesome.
BENT AND BROKEN NEEDLES
Improper animal restraint is the root of most bent-needle problems.
If a needle bends, stop immediately and replace it. Do not straighten
it and use it again. While very rare, you and your veterinarian must
determine how animals will be handled should a needle break off in a
muscle. A broken needle creates an emergency and time will be of the
essence. Broken needles migrate in tissue and, if not immediately handled,
will be impossible to find, requiring the animal to be destroyed. Under
no circumstance should animals with broken needles be sent to a packer.
Purchasing high quality needles, changing and discarding damaged needles,
and providing proper restraint are all preventive measures.
DRUG
STORAGE
Proper storage of drugs and vaccines will help prevent their improper
use and maintain their effectiveness. Drugs should be kept in an area
separate from feeds and out of the reach of children. Read the label
to check temperature conditions for storage as some drugs should be
refrigerated. The label also will have an expiration date. Drugs that
have become outdated should be disposed of in a safe manner.
HEALTH
MANAGEMENT
Health issues that affect the quality of sheep products are the administration
of injections, the use of drugs and vaccines, and the control of internal
and external parasites. Administration of all processing products (vaccines,
dewormers, pour-ons, etc.) needs to be recorded. The record should include
the date, product used, serial/lot number(s) of the product(s), dosage
given, route and location of administration and the withdrawal time
assigned to each product. A good method of recording treatments is individually
identifying each animal in the operation by giving it a tag. The tag
should include a number that identifies each animal by group and, if
possible, an individual number unique to that animal.

ANIMAL HEALTH PRODUCT RECORDS
Animal health product records show origin and expiration dates of each
product used. Most systems fall into one of two categories - receiving
records or inventory records. The most common type of system is an "action"
record describing when, why, where, how, etc., actions were taken to
remain compliant with the criteria. These records allow for tracing
product origination, expiration dates and product use.
Some sheep operations employ an inventory record system that allows
all processing medications to be recorded under a running or beginning
and ending inventory. This also allows for product usage calculation.
Such a record can prove to be a great benefit when charging and billing
customers and can also serve as valuable information in terms of monitoring
management of the production unit.
Several pharmaceutical companies have developed computer programs to
generate records of animal health product inventory. The product used
is recorded at the chute at the time of administration via a chute-side
computer terminal or via a handwritten system consisting of an individual
treatment card or a processing work order form.
Producers should also maintain an accurate documentation system for
needle inventory. This documentation can prove beneficial in documenting
that needles were not broken-off in the muscle tissue when sheep were
processed or treated in the production unit. The information may also
prove valuable in determining if employees need additional training
in the area of processing and appropriate methods of treatment for sheep.
In order to prevent drug residues in sheep products (including meat,
milk and lanolin), proper identification, and record-keeping, of treated
animals is necessary. Sheep treated with drugs should be given a permanent,
unique identification such as by use of an eartag or an electronic implant.
This will prevent them from being lost for further treatment and allow
proper harvest withdrawal to be followed. In addition, the stockman
may wish to use a colored mark on the face or head or a distinguishing
collar for easy recognition. A written record should include identification
of the treated animal, dates of treatment, drug and dose given, withdrawal
time and the person who performed the treatment.
A record of pesticide use must be kept and must include product identification,
serial/lot number, date used, amount used, the person who administered
the pesticide, the animal or animals exposed to the pesticide and withdrawal
time. If a pesticide, such as a pour-on, is used at processing, the
record of its use can be included on the processing record for the group
of sheep. If a premise pesticide is used, a record of its use can be
included on a Premise Pesticide Use Record. Records for Restricted Use
Pesticides (RUP) must be kept for three years.
ACTION
IN CASE OF VIOLATION
If an unacceptable residue is found by FSIS, a joint assessment by the
sheep operation, the veterinarian, the nutritionist, representatives
of FSIS, FDA and the SSQA program will be made and corrective action
taken to prevent recurrence of such violation. Corrective Action is
defined as procedures to be followed when a deviation occurs. All violations
will be reported to the SSQA coordinator and the respective advisory
group for review and action.
INJECTIONS
If intramuscular (IM) medications must be used, administer them in the
neck and never exceed 5 cc per IM injection site. If 12 cc is the calculated
dose, use three, 4 cc injections instead of two, 6 cc injections. Administer
less than 5 cc per IM injection site. The volume of solution injected
at one site will directly influence tissue damage, scar tissue and potential
abscesses. Always use subcutaneous (SQ; under the skin) or intravenous
(IV; in the vein) routes of administration when permitted by the product's
label. Check product labels closely and administer the product as
specified on the label. Select products that have subcutaneous (SQ)
as an approved route of administration. Ask suppliers to find products
that have SQ, IV or oral routes of administration rather than intramuscular
(IM; in the muscle) route of administration.
Summary
of Step 2 Criteria That Can Be Achieved By Use Of Objectives and Procedures
2.1 Keep all records for not less than one year from the date of
transfer or sale of the sheep and have the capability of trace-back.
2.2 Do not allow Extra-label Drug Use (ELDU) of aminoglycosides
(kanamycin, gentamicin, neomycin) or related compounds.
2.3 Record information for all animals treated individually for
problems unique to that animal individually, stating the animal's identification,
drug administered, serial/lot number of the product, dosage used, approximate
weight of animal, route and location of administration, and earliest date
that animal could clear the withdrawal period.
2.4 Record information for all animals that are group processed
or mass medicated, as a group or lot. (Records should include the animal
lot or group identification, product used, serial/lot number of the product,
date treated, dosage used, route and location of administration, and withdrawal
information. Withdrawal information is assigned to the entire pen. Recording
animals under this system assumes that every animal in the lot or group
received the treatment.)
2.5 Make applicable records available to FSIS and FDA personnel
and the SSQA program coordinator if unacceptable levels of residues are
found in any of the sheep shipped for slaughter. (The source and cause
of the violative residue will be determined and corrective action will
be taken to prevent recurrence.)
2.6 Use products with low recommended dosage and administer injections
are administered at proper spacing intervals in the neck and with a minimum
of three inches separating injection sites. Administer IM products with
no more than
5 cc per IM site.
2.7 Attempt always to use products cleared for SQ, IV and oral
administration. |